Ubiquitx
Founded 2021 · 3 employees on LinkedIn · 1 known investors
UbiquiTx develops an AI-native platform for programmable modulation of the proteome, using modular constructs that pair AI-designed guide peptides with swappable effector enzymes to degrade, stabilize, or relocalize target proteins. The company runs a validation business and a therapeutic pipeline in oncology and regenerative disease.
Investors · 1
Frequently asked questions
- What does Ubiquitx do?
- UbiquiTx develops an AI-native platform for programmable modulation of the proteome, using modular constructs that pair AI-designed guide peptides with swappable effector enzymes to degrade, stabilize, or relocalize target proteins. The company runs a validation business and a therapeutic pipeline in oncology and regenerative disease.
- Who are Ubiquitx's investors?
- Ubiquitx's investors include The E14 Fund.